Showing results (11-20 of 83) with videos related to
Sort By:
Pageof 9
Cellular Immunology|February 15, 1983
Lymphokine and phorbol (PMA) regulation of complement (C2) synthesis using U937B H Littman, R E Hall, A V MuchmoreArthritis and Rheumatism|September 1, 1991
Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroidsG S Firestein, M M Paine, B H LittmanArthritis and Rheumatism|October 1, 1987
Elevated plasma C3 anaphylatoxin levels in rheumatoid arthritis patientsG Moxley, S RuddyScience (New York, N.Y.)|September 10, 1976
Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivatorK Whaley, S RuddyThe Journal of Experimental Medicine|November 2, 1976
Modulation of the alternative complement pathways by beta 1 H globulinK Whaley, S RuddyArthritis and Rheumatism|October 1, 1985
Elevated C3 anaphylatoxin levels in synovial fluids from patients with rheumatoid arthritisG Moxley, S RuddyErnst Schering Research Foundation Workshop|November 23, 2006
Experiences with dose finding in patients in early drug development: the use of biomarkers in early decision makingS R Sultana, S Marshall, J Davis, et al.Annals of the Rheumatic Diseases|April 1, 1987
Correlation of immunoglobulin and C reactive protein levels in ankylosing spondylitis and rheumatoid arthritisK M Sanders, A Hertzman, M R Escobar, et al.Annals of the New York Academy of Sciences|June 13, 1975
Activation of the complement and properdin systems in rheumatoid arthritisS Ruddy, K F AustenJournal of Immunology (Baltimore, Md. : 1950)|January 1, 1981
The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosanH A Schenkein, S RuddyPageof 9